ITMI992549A0 - Nuova composizione - Google Patents

Nuova composizione

Info

Publication number
ITMI992549A0
ITMI992549A0 IT99MI002549A ITMI992549A ITMI992549A0 IT MI992549 A0 ITMI992549 A0 IT MI992549A0 IT 99MI002549 A IT99MI002549 A IT 99MI002549A IT MI992549 A ITMI992549 A IT MI992549A IT MI992549 A0 ITMI992549 A0 IT MI992549A0
Authority
IT
Italy
Prior art keywords
new composition
composition
new
Prior art date
Application number
IT99MI002549A
Other languages
English (en)
Inventor
David Philip Elder
Ahmad Khalaf Al Deed A Ghazawi
Meneaud Padma Patel
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9914601.1A external-priority patent/GB9914601D0/en
Priority claimed from GBGB9914709.2A external-priority patent/GB9914709D0/en
Priority claimed from GBGB9927501.8A external-priority patent/GB9927501D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of ITMI992549A0 publication Critical patent/ITMI992549A0/it
Publication of ITMI992549A1 publication Critical patent/ITMI992549A1/it

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2009Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IT1999MI002549A 1999-06-22 1999-12-03 Nuova composizione ITMI992549A1 (it)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9914601.1A GB9914601D0 (en) 1999-06-22 1999-06-22 Composition
GBGB9914709.2A GB9914709D0 (en) 1999-06-23 1999-06-23 Composition
GBGB9927501.8A GB9927501D0 (en) 1999-11-19 1999-11-19 Composition

Publications (2)

Publication Number Publication Date
ITMI992549A0 true ITMI992549A0 (it) 1999-12-03
ITMI992549A1 ITMI992549A1 (it) 2001-06-03

Family

ID=27269749

Family Applications (1)

Application Number Title Priority Date Filing Date
IT1999MI002549A ITMI992549A1 (it) 1999-06-22 1999-12-03 Nuova composizione

Country Status (21)

Country Link
EP (1) EP1064936A1 (it)
AT (1) AT3722U1 (it)
AU (2) AU1573100A (it)
BE (2) BE1012806A3 (it)
CA (1) CA2291542A1 (it)
CH (1) CH690024A5 (it)
DE (2) DE29921300U1 (it)
DK (2) DK199901730A (it)
ES (1) ES2159260B1 (it)
FI (2) FI4488U1 (it)
FR (1) FR2795327A1 (it)
GB (1) GB2351233A (it)
GR (1) GR1003490B (it)
IE (2) IES991108A2 (it)
IT (1) ITMI992549A1 (it)
LU (1) LU90483B1 (it)
NL (2) NL1013750C1 (it)
NO (1) NO995945L (it)
PT (1) PT102384A (it)
SE (1) SE9904404L (it)
WO (1) WO2000078291A1 (it)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH689805A8 (fr) * 1998-07-02 2000-02-29 Smithkline Beecham Plc Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant.
GB0003232D0 (en) * 2000-02-11 2000-04-05 Smithkline Beecham Plc Novel composition
NZ523902A (en) * 2000-08-28 2004-05-28 Synthon Bv Paroxetine compositions and processes for making the same
EP1370515A2 (en) 2000-08-29 2003-12-17 Ranbaxy Laboratories, Ltd. Synthesis of n,n-dimethyl-3-(4-methyl) benzoyl propionamide, a key intermediate of zolpidem
DE20100529U1 (de) * 2001-01-11 2001-05-10 Synthon Bv Pharmazeutische Tablette umfassend Paroxetinmesylat
CA2361882A1 (en) * 2001-10-19 2003-04-19 Bernard Charles Sherman Liquid for oral administration comprising paroxetine
MXPA04007428A (es) 2002-02-01 2004-10-11 Pfizer Prod Inc Formas de dosificacion de liberacion inmediata que contienen dispersiones de farmaco solido.
EP1660496A1 (en) * 2003-07-31 2006-05-31 Ranbaxy Laboratories Limited Process for the synthesis of zolpidem
US20080033050A1 (en) 2006-08-04 2008-02-07 Richards Patricia Allison Tewe Method of treating thermoregulatory disfunction with paroxetine
CN105963273A (zh) * 2016-05-02 2016-09-28 杭州富阳伟文环保科技有限公司 甲磺酸帕罗西汀胶囊及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2096853A1 (en) * 1990-11-24 1992-05-25 Anthony Michael Johnson Use of paroxetine for the treatment of senile dementia, bulimia, migraine or anorexia
GB9514842D0 (en) * 1995-07-20 1995-09-20 Smithkline Beecham Plc Novel formulation
GB9605828D0 (en) * 1996-03-20 1996-05-22 Smithkline Beecham Plc Treatment method
US5874447A (en) * 1997-06-10 1999-02-23 Synthon B. V. 4-Phenylpiperidine compounds for treating depression
CH689805A8 (fr) * 1998-07-02 2000-02-29 Smithkline Beecham Plc Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant.

Also Published As

Publication number Publication date
FIU990494U0 (fi) 1999-12-03
AT3722U1 (de) 2000-07-25
GB9928673D0 (en) 2000-02-02
NO995945D0 (no) 1999-12-03
IE991107A1 (en) 2001-05-30
DE19958228A1 (de) 2000-12-28
DK199900435U3 (da) 2000-02-11
FI4488U1 (fi) 2000-07-20
FI19992609A (fi) 2000-12-22
GR1003490B (el) 2000-11-30
NL1013749C2 (nl) 2001-01-08
ES2159260A1 (es) 2001-09-16
IES991108A2 (en) 2001-04-04
GB2351233A (en) 2000-12-27
LU90483B1 (fr) 2001-01-31
BE1013166A6 (fr) 2001-10-02
PT102384A (pt) 2000-12-29
CA2291542A1 (en) 2000-12-22
BE1012806A3 (fr) 2001-03-06
CH690024A5 (fr) 2000-03-31
DE29921300U1 (de) 2000-02-10
AU727000B3 (en) 2000-11-30
WO2000078291A1 (en) 2000-12-28
NO995945L (no) 2000-12-27
SE9904404L (sv) 2000-12-23
ES2159260B1 (es) 2002-05-01
EP1064936A1 (en) 2001-01-03
NL1013750C1 (nl) 2000-12-28
FR2795327A1 (fr) 2000-12-29
SE9904404D0 (sv) 1999-12-03
DK199901730A (da) 2000-12-23
ITMI992549A1 (it) 2001-06-03
AU1573100A (en) 2001-01-09

Similar Documents

Publication Publication Date Title
ITMI20001450A0 (it) Nuova composizione farmaceutica
IS6120A (is) Lyfjablanda
AR023440A1 (es) Composiciones antitranspirantes
NO20021116D0 (no) Ny sammensetning
NO20016115D0 (no) Substituerte heterocykelkondenserte gamma-karboliner
PT1224180E (pt) Azois substituidos
DE60009740D1 (de) Reinigungszusammensetzung
DE60000776D1 (de) Reinigungsmittelzusammensetzung
ID29785A (id) Komposisi-komposisi sampo
NO20021115D0 (no) Ny sammensetning
DE69922267D1 (de) Bewegliches zusammensetzspiel
ATE257691T1 (de) Schweisshemmende zusammensetzungen
DE69943245D1 (de) Gaserzeugende zusammensetzung
DE60016836D1 (de) Resistzusammensetzung
DE60016948D1 (de) Waschmittelzusammensetzung
DE60022111D1 (de) Waschmittelzusammensetzung
DE60040058D1 (de) Schutzschalter
ITMI992549A0 (it) Nuova composizione
DE60008839D1 (de) Duftstoff-Zusammensetzung
DE60020682D1 (de) Resorcinenthaltende zusammensetzung
DE10080787D2 (de) Mikrobiozide Zusammensetzung
NO20022927D0 (no) Substituerte pyrrazoler
ID27329A (id) Komposisi penghambat
DE60013868D1 (de) Leitfähige zusammensetzung
DE60006734D1 (de) Unterbrecher